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ABSTRACT
Gene expression profiling of formalin-fixed and
paraffin-embedded (FFPE) specimens, banked
from completed clinical trials and routine clinical
care, has the potential to yield valuable information
implicating and linking genes with clinical para-
meters. In order to prepare high-quality cDNA from
highly fragmented FFPE-RNA, previously precluded
from high-throughput analyses, we have designed
a novel strategy based on the nucleic acid restora-
tion of incomplete cDNA sequences prior to T7
in vitro transcription (IVT) amplification. We describe
this strategy as complementary-template reverse-
transcription (CT-RT) because short single-stranded
T7-oligo-dT24-VN-DNA sequences, obtained from
FFPE-RNA, are used as primers for the RT of
complementary RNA templates contained in a
sense-RNA library. We validated our assay by
determining the correlation between expression
profiles of a matched 10-year-old frozen and FFPE
breast cancer sample. We show that T7 IVT-
amplification of cDNA transcripts restored by
CT-RT is a specific and reliable process that
allows recovery of transcriptional features unde-
tectable by direct T7 IVT-amplification of FFPE-RNA.
Furthermore, CT-RT restored 35–41% of the tran-
scripts from archived breast and cervical specimens
when compared to matched frozen tissue; and
profiles included tissue-specific transcripts. Our
results indicate that CT-RT allows microarray profil-
ing of severely degraded RNA that could not be
analyzed by previous methods.
INTRODUCTION
The development of high-density microarrays has enabled
the study of thousands of individual transcripts in parallel
and helped to identify the distinct transcriptional proﬁles
of tumors (1). As a result, hierarchical clustering of these
tumor proﬁles has proven to be valuable for classiﬁcation
of cancers of the same tissue type. One such example has
been the classiﬁcation of gene expression patterns in
primary breast tumors, which led to the identiﬁcation of
four distinct tumor subtypes subsequently linked with
diﬀerent clinical outcomes (2–4). Such studies substantiate
the use of molecular taxonomy in clinical medicine for
accurate cancer diagnosis and especially for identiﬁcation
or design of suitable therapeutic approaches (5–8).
Retrospective transcriptional proﬁling of archived
tissues, especially those collected from subjects for whom
long-term disease outcome is known, represents an
attractive objective for identiﬁcation of novel therapeutic
targets. Unfortunately, the specimens that have been
collected in surgical pathology have been routinely
formalin-ﬁxed and paraﬃn-embedded (FFPE), a preser-
vation process that has been shown to induce the
formation of cross-linkages between proteins and between
proteins and nucleic acids (9). This ﬁxation method
impedes the extraction of large amounts of RNA and is
especially detrimental for single-stranded RNA molecules
that appear fragmented and chemically modiﬁed (10–14).
These characteristics have been major roadblocks for
systematic high-throughput analysis of archived tissues. In
fact, multi-gene retrospective analyses of FFPE-RNA
have been achieved only by in situ hybridization or by
relative quantiﬁcation of target transcripts using real-time
RT-PCR (15–19). Although RT-PCR techniques
have been enhanced for the study of larger gene sets,
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thousands of genes and especially for the identiﬁcation
of novel cancer-related genes, hence the need for devel-
oping more appropriate technologies (14,20–22).
One major disadvantage of microarray analysis is
the requirement for signiﬁcant amounts of high-quality
RNA, which is essential for increased sensitivity and
reproducibility, a standard that cannot be met by
fragmented RNA extracted from archived tissues.
Although a few commercial kits have been designed to
amplify reliably small amounts of starting material,
several studies have pointed out that FFPE-RNA is not
a good substrate for cDNA synthesis (12,23–26). The RT
of fragmented and chemically modiﬁed RNA molecules
gives rise to a population of small cDNA transcripts that
in turn produce short complementary RNA (cRNA)
probes by in vitro transcription (IVT). The presence of
undersized probes, along with ampliﬁed non-speciﬁc
sequences, contributes to the increase of non-speciﬁc
signal and thus dilution of speciﬁc signal in microarray
experiments. There have been a few reports that described
the high-throughput transcriptional proﬁling of FFPE-
RNA, but the use of highly fragmented RNA limits
studies to a small subset of genes (27,28). Recent studies
performed with the Arcturus Paradise Reagents demon-
strated that severely degraded RNA could not be
analyzed, and showed that high-throughput analysis of
clinical samples was limited to only 24% of specimens
archived between two and eight years (29,30).
Considering that the fragmentation of RNA and the
loss of valuable information increase with archival time,
we have developed a reliable technique for microarray
analysis of archived specimens that would otherwise be
rejected because of the poor quality of the recovered
RNA. This strategy has been designed for sequence
selection and extension of short single-stranded DNA
molecules, reverse-transcribed from FFPE-RNA, by copy
of a complementary template (CT). We have termed this
process, complementary-template reverse-transcription
(CT-RT) because intact complementary sense-RNA tem-
plates are annealed to the short single-stranded cDNA
primers derived from FFPE tissue, and reverse-
transcribed. We investigated the correlation between a
matched 10-year-old frozen and 10-year-old FFPE-RNA
derived from human breast cancer tissue using the already
established T7 IVT-ampliﬁcation method and compared
it to our strategy, by cDNA microarray analysis (31).
We demonstrated that the CT-RT process speciﬁcally
increases the size of the cDNA transcripts utilized in the
T7 IVT-ampliﬁcation reactions. We demonstrated the
high reproducibility of this process as well as the increase
of speciﬁc signal in cDNA microarray experiments by
comparison with direct T7 IVT-ampliﬁcation of FFPE-
RNA. We demonstrated that the recovery of single-
stranded DNA primers from old FFPE tissue provides
access to transcripts that are undetectable by IVT-
ampliﬁcation. Using the same RNA-template library for
the restoration of cDNA primers reverse-transcribed
either from breast or from cervical archived tissues,
we further demonstrated the speciﬁcity of CT-RT. Our
analysis reveals that highly fragmented poly(A) transcripts
recovered from older archived tissues can successfully be
restored and lead to the recovery of valuable transcrip-
tional features.
MATERIALS AND METHODS
Reagents
We used universal human reference RNA (UHR;
Stratagene), the quality of which was assessed on a
Bioanalyzer 2100 expert (Agilent). The linear ampliﬁca-
tions were performed using the MessageAmp II aRNA
ampliﬁcation kit from Ambion. The sense RNA template
library was generated with the SenseAmp RNA ampliﬁca-
tion kit from Genisphere (32).
RNA extraction from frozen and FFPE tissues
Matched 10-year-old frozen and 10-year-old FFPE breast
cancer samples were obtained from the Monteﬁore
Medical center, Bronx, NY. Matched 3-year-old frozen
and FFPE cervical samples were also obtained from the
Monteﬁore Medical center. RNA from 10-year-old frozen
tissue was extracted using TRIzol reagent following the
manufacturer’s instructions (Invitrogen). The 10-year-old
breast cancer and the 3-year-old cervical FFPE tissues
were macro-dissected and underwent the same RNA
extraction procedure. Areas of interest were identiﬁed on
H&E slides. Macro-dissection consisted of removing two
to three punches of 1mm from the FFPE tissue, which
yielded 5mg of RNA for the 10-year-old tissue, and
between 5 and 20mg of RNA for the 3-year-old tissue.
The FFPE tissue was de-paraﬃnized using 500mlo f
Hemo-De at room temperature on an agitator, three times
(10). The tissue was washed with 1ml of 100% RNase-free
ethanol three times followed by three washes with 1ml of
95% RNase-free ethanol on ice, for 8min each time (11).
The tissue was then washed with 1ml of 1  PBS DEPC
treated and incubated in 200ml of RNase-Free 1  PBS
and 6.5ml of RNase-Out (Invitrogen) for 90min on ice, for
rehydration. Prior to proteinase K digestion, each tissue
was homogenized in a 7ml Wheaton homogenizer using
2.010ml digesting buﬀer (50mM Tris–HCl pH 7.5, 75mM
NaCl, 5mM CaCl2 and 0.1% SDS). The homogenized
tissue was separated in 15 tubes of 134ml, to which was
added 1ml of RNase out (Invitrogen). A volume of 15ml
of proteinase K at 30mg/ml was added to each tube
(Roche Diagnostics). The digestion was carried out at
598C for 1h, upon agitation every 5min. After 1h, digests
were gathered in two tubes and spun down at 12000 r.p.m.
for 1min. The pellets were kept on ice, and 1ml of
butanol-1 was added to the supernatants. The tubes were
vortexed and spun at 10000 r.p.m. for 1min. The butanol
extractions were repeated to achieve partial removal of
aqueous phase and obtain a ﬁnal volume of 100ml. This
solution was used to re-suspend the tissue pellets, which
led to a ﬁnal volume of 150ml. The solution was
homogenized in 1ml of TRIzol (Invitrogen) following
the manufacturer’s instructions. The RNA present in the
supernatant was precipitated with 1ml of 0.1mg/ml of
linear acrylamide and 3M sodium acetate and 600mlo f
isopropanol. The tubes were incubated for 12h at  208C
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The precipitated RNA was washed with 200ml of 70%
RNase-free ethanol, dried and re-suspended in RNase-
free water (Promega). The RNA was quantiﬁed on a
Nanodrop ND-100 spectrophotometer and analyzed on
Bioanalyzer using the Agilent-2100 software.
First strand cDNA synthesis and purification forthe
CT-RT process
The synthesis of single-stranded DNA primers from
FFPE-RNA was achieved by using 5mg of RNA in a
20ml reaction. For the RT of the FFPE-RNA, we used
Arrayscript (Ambion), the same enzyme as the one
provided in the MessageAmp II RNA kit (Ambion).
Each reaction contained 5mg of RNA, 2mlo f1 0  
arrayscript buﬀer, 1ml of RNase inhibitor mix, 4ml
dNTP mix 2.5mM each (Ambion), 1ml (100ng) of
T7-Oligo dT(24)-VN(50-GGCCAGTGAATTGTAATAC
GACTCACTATAGGGAGGCGGdT(24) (A/C/G)(A/C/
G/T)-30) and 1ml of arrayscript reverse-transcriptase.
The reaction proceeded at 428C for 2h. The 20ml reaction
was brought to 400ml with RNase-free water (Sigma)
for puriﬁcation on a microcon YM-50 (Millipore), as
instructed by the manufacturer. The puriﬁcation was
performed by spinning the YM-50at 500g for 12min to
cut-oﬀ double-stranded cDNA/RNA fragments under
100-bp and single-stranded T7-oligo dT(24) -VN. The
ﬁlter was washed three times using 400ml of RNase-free
water (Sigma). A volume of 88ml was recovered and
incubated with 10mlo f1 0   RNase H buﬀer and 2mlo f
RNase H 10 U/ml (Ambion) for 30min at 378C. The
solution was transferred to a boiling water bath for 3min
and transferred on ice for 5min. The single-stranded
cDNA was puriﬁed using a MinElute puriﬁcation column,
following manufacturer’s instruction (Qiagen). The single-
stranded cDNA was recovered in 10ml and quantiﬁed on
a Nanodrop NO-100 Spectrophometer.
T7in vitro amplifications andCT-RT amplifications
The direct ampliﬁcation of RNA extracted from matched
10-year-old frozen and FFPE breast cancer tissues and
from the 3-year-old frozen cervical tissue were performed
with the MessageAmpII aRNA kit from Ambion, using
5mg of total RNA for each reaction, as instructed by
manufacturer. The T7 IVT-ampliﬁcations proceeded for
14h at 378C. For the restorations, the CT-RT process was
performed using the single-stranded DNA primers
obtained from 5mg of FFPE-RNA from the 10-year-old
breast cancer and the 3-year-old cervical samples. In order
to prevent the T7-oligo dT(24) sequences of the puriﬁed
cDNA primers from priming poly(A) sequences of
random templates in the Sense-RNA template library,
1ml of the Non-Sense Knock-out oligonucleotide (NSK),
50-(A/C/T/G)(C/T/G)dA(24) CCGCCTCCCTATAGTGA
GTCGTATTACAATTCACTGGCC-30 (0.5mg/ml was
added to the 9ml single-stranded cDNA solution. The
mix was incubated for 10min at 708C, 10min from 70
to 378C and at 378C for 10min for hybridization.
The solution was then speed-vacuum-dried to obtain a
ﬁnal volume of 1ml. The sense-RNA template library was
prepared using 2.5mg of fresh UHR RNA (Stratagene)
and ampliﬁed using the SenseAmp RNA Ampliﬁcation
Kit from Genisphere, following the manufacturer’s
instructions. We made one minor change to the procedure,
by adding DNase-I prior to the sense-RNA puriﬁcation in
order to remove any trace of DNA. The integrity of the
UHR-RNA was checked on a Bioanalyzer (Agilent). The
sense-RNA was quantiﬁed using the Nanodrop ND-100
and stored in 10mg/5ml samples at  808C. For the CT-RT
reaction, we annealed 8.8ml of sense-RNA and 1mlo f
puriﬁed cDNA/NSK1 primers in presence of 1.2mlo f1 0  
ﬁrst strand buﬀer and one drop of RNase-free mineral oil
(Sigma). The solution was incubated in a 0.5ml microfuge
PCR tube in a Perkin–Elmer Cetus DNA thermal cycler
with a thermocycle ﬁle as follows: 708C for 10min,
70–428C in 90min. The ﬁrst strand cDNA synthesis was
prepared by adding 1.2ml of RNase-free water, 0.8ml
of 10  ﬁrst strand buﬀer, 4ml of dNTP mix, 1mlo f
ribonuclease inhibitor and 1ml of arrayscript reverse-
transcriptase from the MessageAmp II aRNA kit
(Ambion) and added at the end of the cycle, at 428C
and incubated for 2h at 428C. At the end of the cycle, the
tube was transferred on ice. The second strand cDNA
synthesis mix was prepared (63ml of RNase-free water,
10mlo f1 0   second strand cDNA buﬀer, 4ml of dNTPs,
2ml of DNA polymerase and 1ml of RNase-H) and added
under the mineral oil to the 20ml solution, following the
manufacturer’s instructions (Ambion). The tubes were
incubated for 2h at 168C, the cDNA was puriﬁed and the
aRNA synthesized following the IVT instructions for 14h
(Ambion). The aRNA was quantiﬁed on a Nanodrop
spectrophotometer and analyzed on a Bioanalyzer.
PCR analysesof double-stranded cDNA
Double-stranded cDNA obtained from 5mg of UHR
RNA, 10-year-old frozen RNA, 10-year-old FFPE-RNA
and 10-year-old restored FFPE-cDNA was used for the
PCR reactions. Half the volume of the cDNA recovered
from MessageAmpII cDNApurifying columns was usedto
prepare a master mix for each set of PCR reactions (nine
reactions). Three sets of four primers (Invitrogen), contain-
ing three forward and one reverse-primer, were synthesized
for the three corresponding genes, human Cyclin D1
(Ccnd1; GenBank accession number: 053056), human
tumor protein 53 (p53; GenBank accession number:
000546) and human tyrosine-kinase type-receptor (HER-
2/neu/ERBB2; GenBank accession number: 004448).
For Ccnd1, from 50 to 30 end, forward-primer 1; 50-GT
GATGGGGCAAGGGCACAAGTC-30, Primer 2; 50-CG
GCTGGGTCTGTG-CATTTCTGG-30, primer 3; 50-CCC
AGCACCAACATGTAACCGGC-30 and reverse-primer
50-TGGGGTTTTACCAGTTTTATTTC-30. For p53,
from 50 to 30 end, forward-primer 1; 50-GCTGGTCTCA
AACTCCTGGGCTC-30, primer 2; 50-GTGGAGCTGGA
A-GGGTCAACATC-30, primer 3; 50-CCCACCCTTCC
CCTCCTTCTCCC-30 and reverse-primer; 50-GCAGCAA
AGTTTTATTGTAAAATAAG-30. For Her-2, from 50 to
30 end, forward-primer 1; 50-GCGACCCATTCAGAGAC
TGTCCC-30, primer 2; 50-GTGTCAG-TATCCAGGCTT
TGTAC-30, primer 3; 50-GGGGAGAATGGGTGTTGT
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AGTGGGTGTGGAG-30. Each forward-primer was
paired with the corresponding reverse-primer for each
gene (Ccnd1, p53 and Her-2). All PCR reactions were
performed using the Platinum Taq DNA polymerase high-
ﬁdelity kit, in 50ml reactions (Invitrogen). Each reaction
contained 1ml of cDNA, 2ml of forward- and reverse-
primer (1mg/ml), 2ml of 50mM MgCl2,5 mlo f1 0   high
ﬁdelity buﬀer (600mM Tris–SO4 pH 8.9, 180mM ammo-
nium sulfate), 5ml of 0.2mM of dNTP (2.5mM), 33mlo f
distilled water and a drop of mineral oil. Negative controls
were performed using 1ml of sterile distilled water
instead of cDNA. Platinum Taq high-ﬁdelity polymerase
(2ml of 0.5U/ml) was added after cDNA denaturation for
5min at 958C, reactions were performed in a Perkin–Elmer
Cetus DNA thermal cycler for 30 cycles (958C for 1min,
508C for 1min 30s and 688C for 2min, ending with a
ﬁnal extension step at 688C for 10min). The PCR
amplicons were visualized using a UV light box after
electrophoresis on a 1.5% agarose gel containing 0.5mg/ml
ethidium bromide. The gels were photographed
using a Fluorchem Imager (Alpha Innotech Corporation,
CA, USA).
Cy3/Cy5 labeling ofcRNA andmicroarray hybridization
The cRNA produced from each ampliﬁcation was used to
make ﬂuorescent probes by RT. For each microarray
experiment, 5mg of cRNA synthesized from UHR RNA
(reference) and 5mg of cRNA from our samples were
labeled. The aRNA was incubated in the presence of
2.67ml of random primers (3mg/ml) from Invitrogen in a
ﬁnal volume of 19mla t7 0 8C for 10min, spun down and
put on ice for 5min. Labeling reactions were performed by
adding 8mlo f5   ﬁrst strand buﬀer, 4ml of 0.1M DTT,
4ml of dNTP labeling mix (2.5mM of each), 4mlo f2 5n M
Cy3-labeled deoxyuridine triphosphate (Cy3-dUTP) for
cRNA ampliﬁed from UHR (reference) or 4mlo f2 5n M
Cy5-labeled deoxyuridine triphosphate (Cy5-dUTP;
Amersham Pharmacia Biotech, NJ, USA) for cRNA
from our samples, 1ml of RNase-out at 40U/ml
(Invitrogen), 1.5ml of Superscript II reverse-transcriptase
200U/ml (Invitrogen) and incubated at 428C for 1h.
After 1h of incubation, 1.5ml of Superscript II reverse-
transcriptase was added for another 60min at 428C. The
40ml reactions containing the labeled cDNAs were
incubated in the presence of 44ml of RNase-free water,
10mlo f1 0   RNase-One buﬀer and 2ml of RNase-One
10 U/ml (Promega) for 35min at 378C for removal of
cRNA templates. The RNase-One was then inactivated by
transferring the tubes at 958C for 3min and kept on ice.
The 100ml of Cy3-labeled UHR cDNA and the 100mlo f
Cy5-labeled sample cDNA were combined in a tube
containing 20ml sodium acetate 3M (PH5.1), 2mlo f
0.1mg/ml linear acrylamide (Ambion) and 500ml of 100%
ethanol and precipitated at 14000 r.p.m. for 30min.
The probes were washed with 200ml of 70% RNase-free
ethanol and air dried before being re-suspended in 16.5ml
of RNase-free water for 28000 (28k) features microarrays
and 6.5ml of RNase-free water for 9000 (9k) features
microarrays. The microarray slides were incubated at
508C with 60 or 15ml of pre-hybridization buﬀer for 28k
or 9k microarrays, respectively. The 16.5ml probes were
incubated with 40.5ml of hybridization buﬀer and 3mlo f
human block solution for 28k microarrays and the 6.5ml
probes with 12.5ml hybridization buﬀer and 1mlo f
human block for 9k microarrays. The pre-hybridization
and hybridization buﬀers were supplied by the Albert
Einstein College of Medicine (AECOM) microarray
facility, and human block solution prepared as described
at: http://microarray1k.aecom.yu.edu. After 1h the slides
were washed in distillated water and dried. The 60ml
labeled probe solution was added onto the 28k microarray
slide and covered with a 22 60 premium cover glass, and
the 20ml of labeled probes added onto the 9k microarray
slides and covered with a 22 22 Premium Cover Glass
(Fisher). The microarrays were placed in a sealed chamber
in a water bath at 508C overnight, in the dark. The
slides were washed the following day as described in
Belbin et al. (33). Dry slides were scanned using the
GenePix 4000A microarray scanner (Axon Instruments,
Foster City, CA, USA). The UHR Cy3 (Green) and the
FFPE-RNA Cy5 (Red) images were acquired and gridded
with GenePix Pro 6.0 Software to generate signal
intensities.
cDNA microarray experiments and statistical analysis
Arraysusedforthestudiesweredesignedandprintedatthe
cDNA Microarray Facility, Albert Einstein College
of Medicine (AECOM), Bronx, NY. The 28K arrays
(28704 spots) represent 14725 human cDNA clones of the
distinct genes with sequence annotation and gene ontology
information, 8376 expressed sequence tags (ESTs) with
incomplete sequence annotation, 5603 ESTs without any
available annotation as of the date of the study and
192 bacterial sequences for quality control of the arrays.
The 9K arrays contained 9216 spots (http://microarray1k.
aecom.yu.edu/). The background-subtracted signals were
normalized with a global LOWESS algorithm using
in-house Perl scripts and the R statistical package.
Two-parameter normalization was done between diﬀerent
arrays when necessary. Mean and SD of thesignal intensity
werecalculatedforeachgeneineverygroupoftherepeated
experiments. Missing and low intensity signals (51000)
were excluded from the correlation analysis.
RESULTS
Method design
The fragmented messenger RNA extracted from FFPE
tissue is primed with a T7-oligo dT(24) primer and reverse-
transcribed. The RNA/cDNA duplex is ﬁltered to allow
the removal of single-stranded T7-oligo dT(24) primers
that have not been used up in the reaction, providing
double-stranded fragments longer than 100nt (Figure 1a).
The cDNA that has been synthesized and puriﬁed is
single-stranded by RNA degradation with RNase-H.
A blocking primer, complementary to the T7-oligo
dT(24) sequence of the puriﬁed cDNA, is added to prevent
random annealing of the oligo-dT(24) to the poly(A) tail of
sense-RNA templates. The sense-RNA template library is
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30 end of the ﬁrst strand cDNA, which provides RNA with
the same orientation as messenger RNA (Figure 1b) (30).
Optimal annealing conditions between single-stranded
DNA regions and sense-RNA templates are obtained
in 90min through a temperature gradient from 70 to 428C
(Figure 1c). The RT of the hybridized sense-RNA
templates allows for the extension and thus restoration
of incomplete DNA sequences. The process of CT-RT is
followed by double-stranded DNA synthesis, T7 IVT-
ampliﬁcation and cDNA microarray analysis of the
cRNA (see Supplementary Data for the details of the
method).
CT-RTof a10-year-old archivedbreast cancer sample
We tested our strategy on matched 10-year-old frozen and
10-year-old FFPE samples obtained from the same breast
cancer tissue. After extracting RNA from the frozen
tissue, we performed one round of T7 IVT-ampliﬁcation
with 5mg of total RNA in four individual reactions
(Figure 2a). One of the reactions was stopped after
puriﬁcation of double-stranded DNA for PCR experi-
ments, while the remaining three reactions underwent T7
IVT-ampliﬁcation. Using the FFPE tissue, we extracted
RNA from the same region as from the frozen tissue and
obtained a 260/280 ratio of 1.90. We tested the direct T7
IVT-ampliﬁcation of FFPE-RNA by preparing four
reactions using each 5mg of RNA (Figure 2b). One of
the reactions was stopped after puriﬁcation of double-
stranded DNA (dsDNA) and used for PCR experiments,
while the three remaining reactions underwent T7
IVT-ampliﬁcation. In order to evaluate the restoration
strategy, we prepared four reactions containing 5mgo f
FFPE-RNA each and performed RTs with the reverse-
transcriptase provided in the MessageAmpII ampliﬁcation
kit from Ambion (Figure 2c). After puriﬁcation, for each
reaction we obtained a set of T7-dT (24)-single-stranded
DNA primers that we hybridized with 10mg of sense-RNA
template library. The sense-RNA template library con-
tained templates with sizes ranging between 250 and
1000nt, peaking at 500nt as observed on an Agilent
bioanalyzer 2100 expert (Figure 3a). The size of these
transcripts was shorter than the expected size of tran-
scripts obtain by IVT ampliﬁcation of fresh RNA. The
CT-RT was carried out by adding the reagents provided in
the MessageAmpII aRNA kit (Ambion). The second
strand DNA synthesis was carried out. One reaction was
stopped after cDNA synthesis for PCR experiments, while
the other three underwent T7 IVT-ampliﬁcation.
The CT-RTprocess provides access tolarger cDNA and
cRNA transcripts
In order to investigate the beneﬁt of the CT-RT process
over the single RT of short FFPE-RNA, we compared the
size distribution of cRNA and cDNA products for each of
our T7 IVT-ampliﬁcations on a bioanalyzer 2100 Agilent.
The 10-year-old frozen RNA displayed a degradation
pattern characterized by the absence of 28s ribosomal
RNA and low abundance of 18s RNA, with a ladder-like
pattern (Figure 3b, lane 2). The T7 IVT-ampliﬁcation of
this frozen RNA gave rise to products ranging between
50 and 1000nt, peaking at 200nt (lane 4). Frozen RNA
has been shown to provide shorter cRNA in previous
studies (32). The three ampliﬁcations generated 105,
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Figure 1. Complementary-template reverse-transcription (CT-RT) of
single-stranded DNA primers reverse-transcribed from FFPE-RNA.
(a) RNA extracted from FFPE tissue is reverse-transcribed, the
mRNA/DNA duplex is ﬁltered on an YM-50 column and the DNA
is single-stranded with RNase-H and column puriﬁed. The 50-NB-
Oligo-dA(24)-cT7-30 (complementary to the T7 promoter) is annealed to
the FFPE-cDNA primers. (b) Total RNA from universal human
reference (UHR, Stratagene) is ampliﬁed using the Sense-Amp cRNA
ampliﬁcation kit from Genisphere to provide RNA with the same
orientation as messenger RNA (32). (c) Single-stranded DNA primers
are hybridized to their sense-RNA template between 70 and 428C for
90min. The hybridized products are reverse-transcribed by a process
described as CT-RT. The restored FFPE-cDNAs are doubled stranded
and transcribed in vitro using T7 polymerase. (See Supplementary Data
for technical description of points 1 through 6.)
PAGE 5 OF 14 Nucleic Acids Research, 2007, Vol. 35, No. 15 e9488 and 88.5mg of cRNA. The RNA extracted from the
10-year-old FFPE-RNA provided us with much smaller
products, as most fragments were 5200nt (lane 3). The
T7 IVT-ampliﬁcation of this FFPE-RNA gave rise to
products ranging between 50 and 250nt, which peaked at
125nt, in each of the triplicate reactions (lane 5).
Although the RNA appeared largely degraded, the
ampliﬁcation reactions yielded 44, 40.4 and 32.9mgo f
cRNA, thereby providing suﬃcient amounts for micro-
array analyses. We then analyzed the restored cRNA
obtained by CT-RT reactions, performed on the same
10-year-old FFPE-RNA, and observed a large increase in
the size of the products. The cRNA products ranged
between 50 and 850nt with a peak at 300nt (lane 6). The
CT-RT process produced lower amounts of cRNA in
three reactions, with 28.2, 27.8 and 27.3mg. Considering
that the CT-RT process is based on the increase of
available DNA sequences by a secondary RT of a longer
complementary sense-RNA template, we compared the
dsDNA obtained in our three diﬀerent experiments on
a Bioanalyzer 2100 Agilent (Figure 3c). The dsDNA
generated from 10-year-old frozen RNA appeared the
largest with sizes ranging between 1000 and 2000nt (lane
1). The dsDNA obtained by RT of FFPE-RNA appeared
the smallest with sizes no larger than 200nt (lane 2),
whereas dsDNA obtained by CT-RT of sense-RNA
templates exhibited products as large as 750nt (lane 3).
Taken together, these results indicate that frozen RNA
provides a good template for IVT-ampliﬁcation.
Degraded FFPE-RNA, however, provides much smaller
templates for IVT-ampliﬁcation. The CT-RT of cDNA
obtained from FFPE-RNA appears to provide lengthened
transcripts.
cRNA transcripts obtainedby CT-RT containmore
gene-specific information
In order to verify that the increase in cRNA size, for the
restored material, was due to the RT of CTs, we designed
a PCR experiment to test for the presence of gene and
size-speciﬁc dsDNA molecules. We chose three genes of
signiﬁcance for breast cancer, the human Cyclin D1
(Ccnd1), human tumor protein 53 (p53) and human
tyrosine-kinase type-receptor (HER-2/neu) (34). For each
gene, we designed three sense oligonucleotides increasingly
spaced from the 30end of the transcripts. Then, by
combining each of these diﬀerent sense primers with the
anti-sense primer, in individual PCR reactions, we
determined the amount of sequence available from the
30 end of dsDNA for each gene (see Supplementary Data
for details on the PCR). We ﬁrst tested our PCR reactions
in the absence of a known source of dsDNA, which did
not generate any amplicons (Figure 4, panel 1). Using
dsDNA, obtained by RT and dsDNA synthesis of fresh
UHR RNA with the MessageAmp II ampliﬁcation kit
from Ambion, we validated the presence of each of the
three genes, and demonstrated that their RNA templates
were larger than 250nt by obtaining the largest PCR
products for each of the three genes (panel 2, lanes 3, 6
and 9). We performed these PCR reactions with dsDNA
obtained from RNA extracted from 10-year-old frozen
tissue and detected each of the three diﬀerent PCR
products for each of the three genes, thus demonstrating
1234 1234
10-year-old frozen tissue 10-year-old formalin-fixed paraffin-embedded tissue
Frozen-RNA FFPE-RNA
Breast cancer tissue (1996)
1234
dsDNA synthesis
ssDNA synthesis
PCR
T7 IVT-amplification PCR
cRNA Synthesis
a
dsDNA synthesis
b c
dsDNA synthesis
PCR
Restoration
4 reactions 4 reactions 4 reactions
3 cDNA microarrays
T7 IVT-amplification
cRNA Synthesis
3 cDNA microarrays
T7 IVT-amplification
cRNA Synthesis
3 cDNA microarrays
Figure 2. Experimental procedure utilized for the analysis of 10-year-old matched frozen and formalin-ﬁxed paraﬃn embedded breast cancer
samples. (a) Five micrograms of RNA extracted from the 10-year-old frozen portion of the sample, is reverse-transcribed and the cDNA is double
stranded (dsDNA), in four individual reactions. The dsDNA of three reactions undergoes IVT-ampliﬁcation (MessageAmpII, Ambion), which gives
rise to complementary RNA (cRNA) for cDNA microarray analyses. The dsDNA of one reaction is used for PCR experiments. (b) Five micrograms
of RNA extracted from the 10-year-old FFPE portion of the sample underwent the exact same process. (c) Single-stranded DNA (ssDNA) obtained
by RT of 5mg of FFPE-RNA is puriﬁed and hybridized to the sense-RNA template library. The restored ssDNA is double stranded and puriﬁed.
Three of the CT-RT reactions undergo IVT-ampliﬁcation, while the dsDNA of one reaction is used for PCR experiments.
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Figure 3. Size distribution of mRNA, cRNA and dsDNA on Agilent 2100 Bioanalyzer 6000 Nanochips. (a) Universal Human Reference (UHR)
RNA and sense-RNA template library after IVT-ampliﬁcation. Lane L displays the ladder (25, 200, 500, 1000, 2000 and 4000nt). Lane 1 contains
fresh UHR RNA. Lanes 2, 3 and 4 display three individual IVT-ampliﬁcations of sense-RNA using total RNA displayed in lane 1. (b) Size
distribution of fresh, frozen, FFPE-RNA and ampliﬁed cRNA. Lane L displays the same ladder as observed in (a). Lane 1 contains fresh human
breast RNA. Lane 2 contains total RNA from the 10-year-old frozen human breast cancer tissue. Lane 3 contains total RNA from the matched
10-year-old FFPE human breast cancer tissue. Lane 4 contains cRNA obtained by IVT-ampliﬁcations of 10-year-old frozen RNA (lane 2).
Lanes 5 contains cRNA obtained by direct IVT-ampliﬁcation of the 10-year-old FFPE-RNA (lane 3). Lanes 6 contains ampliﬁed cRNA obtained by
CT-RT and IVT-ampliﬁcation of the same 10-year-old FFPE-RNA. (c) Size distribution of double-stranded DNA on a Bioanalyzer 2100
Agilent nanochip. Lane L displays the ladder. Lane 1 displays dsDNA obtained from 10-year-old frozen RNA. Lane 2 displays dsDNA obtained
from 10-year-old FFPE-RNA. Lane 3 shows dsDNA obtained after CT-RT and double-strand DNA synthesis of the same 10-year-old FFPE-RNA.
(See Supplementary Data for fragmented RNA proﬁles)
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each gene (Figure 4, panel 3). Although the PCR
experiments were performed with the same conditions as
with dsDNA obtained from fresh UHR-RNA, we
detected an increased number of non-speciﬁc products.
These results suggested that fragmented frozen RNA may
provide partial templates for annealing of the short PCR
primers. We then performed PCR reactions with dsDNA
obtained from RNA extracted from 10-year-old FFPE
tissue, and veriﬁed the presence of the three genes by
detecting the smallest PCR amplicons (Figure 4, panel 4,
lanes 1, 4 and 7). The detection of these products revealed
that short dsDNA templates were present, for all three
genes, but did not exceed at 150bp, thus demonstrating
the absence of dsDNA of 251bp for Ccnd1, 214bp for p53
and 225bp for Her-2 (Figure 4, panel 4). These PCR
results corroborated the bioanalyzer analyses, which
suggested that RNA from 10-year-old FFPE tissue
contained transcripts around 100nt and no larger than
165nt. When we performed these PCR reactions with
dsDNA obtained by RT of the FFPE-RNA and restored
by the CT-RT process, we were able to detect much larger
products for each of the three genes (Figure 4, panel 5).
We then cloned and sequenced the largest PCR amplicons
of each of the three genes, and veriﬁed that these
sequences were 100% speciﬁc to each of the three genes
(Figure 4, panel 5, lanes 3, 6 and 9). Taken together, these
results demonstrated that the RT of older FFPE-RNA
provides short but speciﬁc DNA transcripts that eﬀec-
tively match the ones detected in frozen RNA. When these
cDNA transcripts were used for the CT-RT of cRNA
templates, a physical restoration of gene-speciﬁc sequences
was detected. The T7 IVT-ampliﬁcation of larger cDNA
templates produces larger cRNA transcripts.
The CT-RT process providesreliable cRNA for
transcriptional profiling
In order to evaluate the robustness of the CT-RT process
we analyzed the cRNA, obtained after subsequent IVT-
ampliﬁcation, on cDNA microarrays (Figure 5). For
quality control, each cDNA microarray was hybridized
with both Cy5-labeled material (the experiment) and Cy3-
labeled UHR cRNA (the reference). We ﬁrst investigated
the robustness of the IVT-ampliﬁcation process. We
examined the correlation in gene expression between
technical repeats using cRNA obtained from fresh UHR
RNA (Cy3) on cDNA microarrays (Figure 5a). The
coeﬃcient of determination (R
2=0.9495), which was
high, demonstrated the strength of the linear relationship
between repeats and thus the reliability of the IVT-
ampliﬁcation. We performed the same measurements with
cRNA ampliﬁed from partially degraded RNA extracted
from 10-year-old frozen tissue, and obtained similarly
high coeﬃcient of determination (Figure 5b, R
2=0.9425).
These results demonstrated that the MessageAmpII
aRNA kit from Ambion provided high performance
IVT-ampliﬁcations even with partially degraded RNA.
We then evaluated the quality of the cRNA ampliﬁed
directly from RNA extracted from 10-year-old FFPE
tissue. The coeﬃcient of determination was much lower
(R
2 between 0.5684 and 0.6201), reﬂecting that the
correlation between technical repeats might be impeded
by the degradation and/or the chemical modiﬁcation of
FFPE-RNA (Figure 5c). We then evaluated the robust-
ness of the CT-RT process, when performed with RNA
extracted from the 10-year-old FFPE tissue, by cDNA
microarray analysis of technical repeats (Figure 5d).
The coeﬃcient of determination was signiﬁcantly higher
(R
2 between 0.8621 and 0.8495) than the ones obtained by
direct IVT-ampliﬁcation of FFPE-RNA. Together, these
results demonstrated that single-stranded DNA, obtained
from highly degraded and chemically modiﬁed and older
FFPE-RNA, provides a highly reliable material for
CT-RT reactions and IVT-ampliﬁcations.
CT-RT improves thecorrelation between FFPE and frozen
RNA expression profiles
We then sought to evaluate the amount of information
that could be retrieved from RNA extracted from the
10-year-old FFPE tissue by comparison with transcrip-
tional information contained in messenger RNA from the
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Figure 4. The size of double-stranded DNA molecules is determined by
PCR experiments. Size distribution of the PCR products on a 1%
agarose gel. The ﬁrst lane of each gel displays the ladder (500, 400, 300,
200 and 100bp from top to bottom of gel). Lanes 1–9 show the PCR
products from three primer pairs for Ccnd1, three primer pairs for p53
and three primer pairs for Her-2. Panel 1 shows PCR experiments
performed without DNA, panel 2 with dsDNA generated from UHR
RNA, panel 3 with dsDNA obtained from 10-year-old frozen RNA,
panel 4 with dsDNA obtained from 10-year-old FFPE-RNA and panel
5 with dsDNA restored by CT-RT (See Supplementary Data for PCR
details).
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ampliﬁcation or the CT-RT process followed by
IVT-ampliﬁcation. Using the microarray data, we deter-
mined that the number of observable spots with a signal
higher than 1000 in each the red (Cy5) and the green (Cy3)
channels was almost four times higher with the CT-RT
process (4583) than by direct IVT-ampliﬁcation of FFPE-
RNA (1306; Table 1). Our data also revealed that the
number of spots, displaying520% of variability with the
signal of matching spots from frozen material, was ﬁve
times higher by the CT-RT process (2475) than by direct
IVT-ampliﬁcation (490) of the 10-year-old FFPE-RNA
(Table 1). These results indicated that the CT-RT process
allowed for a more reliable and a signiﬁcantly higher
recovery of features from the 10-year-old FFPE tissue.
These features could not be detected by microarray
analysis of material obtained by direct IVT-ampliﬁcation
of RNA from 10-year-old FFPE tissue. We chose one
sample grid from our diﬀerent microarray experiments to
display the signal intensity generated by Cy5-labeled
probes obtained by RT of the diﬀerent cRNAs
(Figure 6a). We determined that the cRNA obtained by
direct IVT-ampliﬁcation of RNA from 10-year-old FFPE
tissue generated the lowest intensity (FFPE-Amp 1–3),
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Figure 5. Scatter plots comparing the log2 ratios of experimental repeats. (a) Graph displaying the correlation between IVT-ampliﬁcations of fresh
universal human reference RNA (Figure 3a, lane 1) in the green channel (Cy3), used as the reference. The coeﬃcient of determination is displayed in
the top right corner, R
2=0.9495. (b) Graph displaying the correlation between IVT-ampliﬁcations from 10-year-old frozen RNA (Figure 3b, cRNA
lanes 4 and 5) in the red channel (Cy5). The coeﬃcient of determination between both experiments is displayed in the top right corner, R
2=0.9425.
(c) This scatter plot shows the correlation between IVT-ampliﬁcation from 10-year-old FFPE-RNA (Figure 3b, cRNA lanes 8 and 9) in the red
channel (Cy5). The R
2 is displayed in the top right corner, and is 0.5684. (d) This scatter plot displays the correlation between restorations using the
same 10-year-old FFPE-RNA (Figure 3b, lanes 11 and 12) in the red channel (Cy5). The coeﬃcient of determination between restoration 2 and
restoration 3 is displayed in the top right corner, R
2=0.8641.
Table 1. Transcripts detected after IVT-ampliﬁcation of 10-year-old
frozen, IVT-ampliﬁcation of 10-year-old FFPE-RNA and after
restoration by CT-RT followed by IVT-ampliﬁcation of 10-year-old
FFPE-RNA
Frozen FFPE-
Ampliﬁed
FFPE-
Restored
Number of good spots 25791 22838 22997
Number of spots with
red (Cy5) and green
(Cy3) intensities >1000
4535 1306 4583
Number of measurements
with variability <20%
2878 490 2475
PAGE 9 OF 14 Nucleic Acids Research, 2007, Vol. 35, No. 15 e94where cRNA obtained by CT-RT and IVT-ampliﬁcation
(FFPE-Restored 1–3) provided access to transcripts with
matching signal intensities to the transcripts detected in
10-year-old frozen tissue (Frozen 1–3). In order to
compare the amount of signal available on the arrays,
we chose to analyze genes with expression ratios ranging
between 0.5 and 2 in frozen tissue. We selected a set of
genes detected in both frozen RNA and in UHR RNA,
and generated a heat map for 1044 genes with expression
ratios between 0.5 and 2 (Figure 6b, Frozen-Amp 1–3).
The UHR RNA was utilized to generate sense-RNA
library that provided the templates used by CT-RT in
restoration experiments. We observed that the restoration
by CT-RT (FFPE-Restored 1–3) provided access to a
much larger set of genes with expression ratios over-
lapping the ones from frozen material, than direct IVT-
ampliﬁcation of FFPE-RNA (FFPE-Amp 1–3). We
determined that the total number of transcripts recovered
from 10-year-old FFPE tissue with ratios matching the
ones of transcripts from frozen tissue was three times
higher after restoration (3562) than after direct IVT-
ampliﬁcation (1218, Table 2). Furthermore, the coeﬃcient
of determination was four times higher (R
2=0.38) than
after IVT-ampliﬁcation of FFPE-RNA (R
2=0.10),
FFPE-Amp 1-3 FFPE-Restored 1-3 Frozen-Amp 1-3 Frozen-Amp 1-3
(a) (b)
FFPE-Restored 1-3
FFPE-Amp 1-3
Log2 Ratio
−8 −2 4
Figure 6. Signal intensity and heat-map analysis of the correlation between the log2 ratios measured by cDNA microarrays. (a) Signal intensity
of one sample grid in the red channel (Cy5) across all microarrays. Top three panels display the grids obtained from three repeats using cRNA from
10-year-old frozen RNA (Frozen-Amp 1–3). Three mid-panels show the signal of three repeats using cRNA obtained by restoration and IVT-
ampliﬁcation of RNA from 10-year-old FFPE tissue (FFPE-Restored 1–3). Three bottom panels display the signal of three repeats using cRNA
obtained by direct IVT-ampliﬁcation of RNA from 10-year-old FFPE tissue. (b) Heat map displaying the log2 of expression ratios ranging between
0.5 and 2 for 1044 genes detected in frozen tissue on a 28032 features cDNA microarray and represented in the UHR library. From left to right are
displayed the ratios obtained by IVT-ampliﬁcation of RNA from 10-year-old frozen tissue (Frozen-Amp 1–3), restoration and IVT-ampliﬁcation of
RNA from 10-year-old FFPE tissue (FFPE-Restored 1–3) and direct IVT-ampliﬁcation of RNA from 10-year-old FFPE tissue (FFPE-Amp 1–3).
Each column represents an individual hybridization and each line a diﬀerent feature. Red and blue represent up-regulated and down-regulated genes,
respectively.
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selected features with expression ratios ranging between
0.5 and 2, we detected after restoration (2395) more than
three times the number of genes after IVT-ampliﬁcation
(785). For these genes, the CT-RT process provided a
coeﬃcient of determination 25 times higher (R
2=0.50)
than the one obtained by IVT-ampliﬁcation (R
2=0.02).
Together, these results demonstrated that the restoration
of FFPE material provides access to a larger set of
transcripts, which display higher intensities possibly due
to their elongation during the process of CT-RT. Our
results demonstrate that the transcripts detected in
restored experiments correlate better with the ones
detected in frozen RNA than those detected by direct
IVT-ampliﬁcation of FFPE-RNA.
CT-RT ofsingle-stranded DNA primers provides
tissue-specific information
We then assessed the reproducibility and the reliability of
the CT-RT process for distinguishing archived clinical
samples that provide severely degraded RNA. We chose to
compare a 3-year-old matched frozen and formalin-ﬁxed
normal cervical sample to the 10-year-old matched frozen
and formalin-ﬁxed breast cancer sample (Figure 7). For
these experiments, total RNA isolated from the 3-year-old
cervical frozen and formalin-ﬁxed tissues, as well as the
cRNA obtained by IVT-ampliﬁcation of frozen RNA or
by CT-RT and IVT-ampliication of FFPE-RNA were
analyzed on the Agilent 2100 bioanalyzer (Supplementary
Data). In order to compare the cRNA derived from
IVT-ampliﬁcations of 10-year-old breast cancer and the
3-year-old cervical frozen tissues, we performed a dye-ﬂip
experiment to minimize labeling bias. By overlapping the
genes detected by Cy3 and by Cy5 dyes, for each sample,
we identiﬁed the expressed genes in each tissue (Table 3).
This dye-ﬂip experiment was then performed with cRNA
obtained by CT-RT and IVT-ampliﬁcation of 10-year-old
breast cancer and 3-year-old cervical FFPE RNAs.
Comparison to the transcripts detected in frozen samples
revealed that 41.3% of the breast transcripts and 35.7%
of the cervical transcripts were restored (Table 3). The
overlap between transcripts detected in frozen and
restored FFPE materials was calculated to be  89%
with  10% false positives (Table 3). We analyzed the
transcriptional proﬁles of the two tissues for the presence
of tissue-speciﬁc features. By comparing the microarray
proﬁles of frozen breast cancer and cervical tissues, we
identiﬁed 905 breast-speciﬁc genes and 1013 cervix-speciﬁc
genes (Table 4). The comparison between restored
transcriptional proﬁles from the breast cancer and cervical
samples identiﬁed 42 breast-speciﬁc and 109 cervix-speciﬁc
transcripts. Comparison of tissue-speciﬁc transcripts
revealed that 3.4% of the breast-speciﬁc and 6.8% of
the cervix-speciﬁc transcripts were restored. It is impor-
tant to note that the sense-RNA library (UHR), which
was used for the restoration of our FFPE samples, was
obtained by pooling 10 diﬀerent tissues and primarily
provided high concentrations of transcripts common to
all the tissues giving a selection bias for common
transcripts. Thus, transcripts speciﬁc to one tissue were
diluted by a 1/10 ratio and therefore might have been too
low in abundance, which could explain the relatively
higher yield for all transcripts (35–41%) versus the lower
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Figure 7. Electropherogram of total RNA recovered from FFPE
samples utilized in CT-RT experiments. Total RNA extracted from
10-year-old breast cancer and 3-year-old cervical FFPE tissues were
loaded on a Agilent 2100 Bioanalyzer 6000 Nanochip.
Electropherograms were obtained with the 2100 expert software from
Agilent, version B.02.03.SI307. 18S and 28S ribosomal RNA peaks are
not detected in either FFPE sample, indicative of severe degradation.
Table 2. Correlation between transcriptional proﬁles obtained from
10-year-old matched frozen and FFPE tissues
Frozen versus
FFPE-Ampliﬁed
Frozen versus
FFPE-Restored
Number
of genes
R
2 (Cy5) Number
of genes
R
2 (Cy5)
Correlation between
spots with
intensities >1000
1218 0.10 3568 0.38
Correlation between
spots with ratios
between 0.5 and 2
785 0.02 2395 0.50
Material obtained by IVT-ampliﬁcation of RNA from 10-year-old
frozen is compared to material recovered by IVT-ampliﬁcation of RNA
from 10-year-old FFPE tissues. Material obtained by IVT-ampliﬁcation
of RNA from 10-year-old frozen is compared to material recovered by
CT-RT and IVT-ampliﬁcation of RNA from 10-year-old FFPE tissues.
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experiments demonstrated that single-stranded DNA
primers representing the 30 region of mRNA, adjacent
to the poly(A) tail, contain suﬃcient information for
retrieval of tissue-speciﬁc transcripts by -CT-RT.
DISCUSSION
The successful analysis of RNA extracted from archived
samples has been achieved in studies that targeted a
limited number of genes. One such remarkable example is
the resolution of the crystal structure of a major surface
antigen of the extinct 1918 ‘Spanish’ inﬂuenza virus, which
killed over 20 million people worldwide. This was
determined after reassembly of the hemagglutinin gene
from viral RNA fragments retrieved from 1918 formalin-
ﬁxed lung tissues (35,36). Although RNA from FFPE
tissue is fragmented and chemically modiﬁed, RT-PCR
experiments have successfully demonstrated the presence
of valuable stretches of information spanning over a
100nt (14,20,21,37,38). Taking advantage of the presence
of these sequences, we devised a novel strategy for the
molecular restoration of valuable portions of information
lost through ﬁxation and extended storage. This novel
technology has the potential to provide a tool for the
retrospective high-throughput analysis of older archived
samples and therefore the recovery of valuable transcrip-
tional information.
The transcriptional proﬁling of moderately
degraded RNA, submitted to multiple rounds of IVT-
ampliﬁcations, has been shown to provide reasonable
results (39). Similar studies using IVT-ampliﬁcations
based on the random priming of degraded RNA indicated
also that microarray analyses might also be feasible with
FFPE-RNA (25,40,41). It has been shown, however, that
the extent of fragmentation, which signiﬁcantly increases
with archive storage time, may become a detriment to the
eﬃcient detection of transcripts by microarray analysis
(14). Our results strongly corroborated these ﬁndings,
as RNA recovered from a 10-year-old archived tissue
appeared largely degraded, with fragments peaking at
165nt and smaller than 200nt. The microarray analysis of
cRNA obtained by IVT-ampliﬁcation of 10-year-old
FFPE-RNA revealed that the correlation between experi-
mental repeats was much lower than repeats performed on
10-year-old frozen RNA (23). Although the ampliﬁcations
provided suﬃcient amounts of cRNA, our experiments
revealed that the short size of the products might have
contributed to the loss of signal as well as the generation
of non-speciﬁc signal. Our ﬁndings suggest that the
process of T7 driven IVT-ampliﬁcation may have primar-
ily beneﬁted short transcripts, non-speciﬁc messages or
other species of RNA carrying poly(A) stretches, thereby
severely decreasing the correlation between expression
proﬁles of experimental repeats as well as the correlation
with frozen material. It is important to note that T7 RNA
polymerase has been shown to be abortive and less
eﬃcient with linear cDNA transcripts containing the T7
promoter, a process that might also contribute to the
shortening of cRNA transcripts during ampliﬁcation of
small cDNA molecules (42, 43, 44).
The purpose of our study was to improve the quality
and the speciﬁcity of microarray analyses performed with
cRNA obtained from old FFPE material that contains
severely fragmented RNA and that is routinely rejected
from high-throughput analyses (29,30). RNA fragmenta-
tion and/or degradation are processes encountered with
older FFPE tissues or samples that have been improperly
ﬁxed, and have remained major roadblocks for reliable
microarray analyses (29,30). In fact, when Penland et al.
used the state-of-the-art Paradise Reagent System from
Arcturus on 2 to 8-year-old FFPE tissues, 76% of the
archived clinical samples were rejected from microarray
proﬁling due to poor RNA quality (30). Therefore, we
designed the process of CT-RT to strengthen transcript
selection prior to IVT-ampliﬁcation and in turn strengthen
signal detection in microarray experiments, when using
RNA of the poorest quality. This process was designed to
investigate the small single-stranded DNA primers
synthesized from highly fragmented messenger RNA, by
hybridization and RT of sense cRNA templates. This
strategy was built around the already established and
widely used T7 IVT-ampliﬁcation method in order to
minimize variables in our experiments. Using PCR
experiments, we showed that this process increased the
50 region of cDNA molecules by at least 100nt in length.
Although the CT-RT process required the preliminary
puriﬁcation of DNA primers on a ﬁlter and a column, our
results indicated that these steps contributed to the
Table 3. Transcript detection by CT-RT of 10-year-old breast cancer
and 3-year-old cervical FFPE samples
Breast tissues Cervical tissues
Number of genes detected in
Frozen, intensities >1000
2639 3273
Number of genes detected in
FFPE-Restored, intensities >1000
1222 1299
Number of genes restored
detected in Frozen
1091 1167
% of genes in restored detected
in Frozen
89.3% 89.8%
Number of genes restored not
detected in Frozen
131 132
% of genes in restored not
detected in Frozen
10.7% 10.2%
% of overall recovery 41.3% 35.7%
Table 4. Detection of tissue-speciﬁc transcripts after CT-RT in
10-year-old breast cancer and 3-year-old cervical FFPE samples
Breast tissue Cervical tissue
Tissue-speciﬁc genes detected in
Frozen, intensities >1000
905 1013
Tissue-speciﬁc genes detected in
FFPE-Restored, intensities >1000
42 109
Number of tissue-speciﬁc genes
restored and detected in Frozen
31 69
% of tissue-speciﬁc genes restored
and detected in Frozen
3.4% 6.8%
e94 Nucleic Acids Research, 2007, Vol. 35, No. 15 PAGE 12 OF14improvement of T7 IVT-ampliﬁcation of older FFPE
material. Our experiments also showed that the RT of CTs
was a highly reproducible mechanism as we obtained
coeﬃcient of determination between 0.84 and 0.86, for
material as old as 10 years. When we correlated the
transcriptional proﬁles from frozen and FFPE tissues, our
method allowed 35–41% of transcript recovery for gene
ratios ranging between 0.5 and 2, where the direct IVT-
ampliﬁcation of FFPE-RNA only provided 2% of
recovery. Our results support the hypothesis that short
transcripts recovered from archival material might be
a major source of non-speciﬁc signal as well as a
contributing factor to the loss of signal. By contrast,
transcript restoration by CT-RT dramatically improves
transcript selection and in turn the correlation between
transcriptional proﬁles of matched frozen and FFPE
material, and this process has the advantage to provide T7
RNA polymerase with longer cDNA molecules for IVT.
The extension of short single-stranded DNA primers by
RT of complementary sense-RNA templates, represented
in excess in a library, is a reaction that gives access to genes
that are still represented in highly fragmented FFPE-RNA
but that cannot be detected by direct IVT-ampliﬁcation.
CT-RT is a multiplex process that can be performed in a
single reaction and may lead to the recovery of thousands
of biologically signiﬁcant transcripts from valuable
archived clinical samples. Sense-RNA templates are
selected by the DNA primers, synthesized from the
archived RNA, during the annealing reaction. These
short DNA primers, although representative of the 30
region of mRNA transcripts, adjacent to the poly(A) tail,
demonstrated to contain speciﬁc and suﬃcient information
to recognize CTs contained in a sense-RNA library (45,46).
Therefore, the restoration of single-stranded DNA pri-
mers, synthesized from highly degraded RNA, is a reaction
that has the potential to lead to the retrospective
identiﬁcation of transcriptional biomarkers that have
remained in the archived tissues as fragmented sequences.
The focus of our work was to establish a reliable
method for the high-throughput analysis of severely
degraded RNA typically recovered in 76% of archived
clinical samples (30). Our results demonstrated that
CT-RT provided access to biologically relevant genes,
which could discriminate between two diﬀerent tissues.
It is important to note that the use of a generic library,
where transcripts from 10 diﬀerent tissues have been
gathered, might not provide optimal tissue-speciﬁc sense-
RNA concentration for the annealing of single-stranded
DNA transcripts that are recovered in low abundance in a
single tissue. Our experiments suggested that transcript
recovery by CT-RT might depend upon the presence of
the CT in the sense-RNA library as much as its
representation in the single-stranded DNA primer pool.
Therefore to improve the process of CT-RT as well as its
eﬃciency, we propose that the selection of speciﬁc libraries
containing a complete array of tissue, disease and/or
tumor-speciﬁc transcripts might provide access to more
informative and more complete transcriptional proﬁles
when using highly fragmented FFPE-RNA from a speciﬁc
tissue. The CT-RT process might also be improved by
increasing the amount of recovered single-stranded DNA
primers. The use of magnetic micro-beads may provide
better mRNA recovery and thus increase the amount of
primers for application of the CT-RT process to smaller
FFPE-RNA fractions. (47). It should be noted that the
CT-RT process may bias alternative splicing proﬁles
of transcripts containing identical 30 regions, towards
that of the reference template, but the overall cumulative
expression level of the splicing variants in the group
should remain intact. In summary, this novel technique
provides the basis for a new molecular approach to the
microarray analysis of severely degraded RNA, recovered
from most archived clinical samples.
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